Evidence map›Paper›PMID 41018874›Full record

ArticleJournal of pharmacopuncture2025

Antibacterial and Antibiofilm Properties of Kulim Bark (

Rafika Sari, Sylvia Utami Tunjung Pratiwi, Yosi Bayu Murti, Ema Damayanti

Abstract read
In one paragraph

Article in Journal of pharmacopuncture, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rafika SariDoctoral Program Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia.ORCID https://orcid.org/0000-0002-8477-119X
Sylvia Utami Tunjung PratiwiDepartment of Pharmaceutical Biology, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia.ORCID https://orcid.org/0000-0002-3254-9407
Yosi Bayu MurtiDepartment of Pharmaceutical Biology, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia.ORCID https://orcid.org/0000-0001-7538-3817
Ema DamayantiBiofilm Research Collaboration Centre (UGM-BRIN), Yogyakarta, Indonesia.ORCID https://orcid.org/0000-0002-4017-0499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The study aimed to analyze the antibacterial and antibiofilm activity of hydrogels from Kulim ( Methods: The stem bark extract and fraction of Kulim ( Results: Kulim extract hydrogel (4 μg/µL) showed 69.16% antibacterial activity and 61.25% biofilm inhibition, with 72.58% and 82.86% biofilm degradation at 24 and 48 hours, respectively. The fraction-based hydrogel (0.22 μg/µL) had 58.10% antibacterial and biofilm inhibition activity, with 81.14% and 79.64% degradation at 24 and 48 hours. MIC50 and MBIC50 values were 2.42 μg/µL (extract) and 0.15 μg/µL (fraction) as well as 2.83 μg/µL and 0.19 μg/µL, respectively. Based on observation, MBEC50 values were 1.09 μg/µL and 0.57 μg/µL (24 h), as well as 0.70 μg/µL and 0.03 μg/µL (48 h), respectively, while the extract's LC50 was 0.143 mg/mL. Conclusion: The hydrogel made from Kulim stem bark extract exhibited stronger antibacterial and antibiofilm activities than the ethyl acetate fraction against polymicrobial.

Indexed as

antibacterialantibiofilmhydrogelKulim barkpolymicrobialRasbora lateristriata

Identifiers

PMID41018874
PMCPMC12464082

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.